Journal of Surgical Research
Volume 140, Issue 1 , Pages 12-19 , 1 June 2007

Loss of the Tight Junction Protein ZO-1 in Dextran Sulfate Sodium Induced Colitis

Received 30 September 2005

References 

  1. Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal permeability in patients with Crohn’s disease and their relatives a possible etiologic factor. Ann Intern Med. 1986;105:883
  2. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions (IV. Regulation of tight junctions by extracellular stimuli: Nutrients, cytokine, and immune cells). Am J Physiol Gastrointest Liver Physiol. 2000;279:G851
  3. Fanning AS, Jameson BJ, Jesaitis LA, et al. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998;273:29745
  4. Itoh M, Furuse M, Morita K, et al. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol. 1999;147:1351
  5. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol. 2001;281:G216
  6. Kucharzik T, Walsh SV, Chen J, et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159:2001
  7. Poritz LS, Lynch CJ, Tilberg AF, et al. Decreased expression of occludin in the intestine of patients with inflammatory bowel disease. FASEB J. 1997;11:A310
  8. Kitajima S, Takuma S, Morimoto M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim. 1999;48:137
  9. Soderholm JD, Olaison G, Peterson KH, et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn’s disease. Gut. 2002;50:307
  10. D’Inca R, Di Leo V, Corrao G, et al. Intestinal permeability test as a predictor of clinical course in Crohn’s disease. Am J Gastoenterol. 1990;94:2956
  11. Hilsden RJ, Meddings JB, Hardin J, et al. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn’s disease relapse. Inflamm Bowel Dis. 1999;5:85
  12. Pironi L, Miglioli M, Ruggeri E, et al. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn’s disease. Dig Dis Sci. 1990;35:582
  13. Wyatt J, Vogelsang H, Hubl W, et al. Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet. 1993;341:1437
  14. Cooper HS, Murthy SNS, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238
  15. Lange S, Delbro DS, Jennische E. Evans Blue Permeation of intestinal mucosa in the rat. Scand J Gastroenterol. 1994;29:38
  16. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694
  17. Koltun WA, Tilberg AF, Page MJ, et al. Bowel permeability is improved in Crohn’s disease after ileocolectomy. Dis Colon Rectum. 1998;41:687
  18. Mahler M, Briston IJ, Leiter EH, et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol. 1998;274:G544
  19. Venkatraman A, Ramakrishna S, Pulimood AB, et al. Increased permeability in dextran sulphate colitis in rats: Time course of development and effect of butyrate. Scand J Gastroenterol. 2000;10:1053
  20. Schmitz H, Barmeyer C, Fromm M, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999;116:301
  21. Schmitz H, Barmeyer C, Gitter AH, et al. Epithelial barrier and transport function of the colon in ulcerative colitis. Ann NY Acad Sci. 2000;915:312

PII: S0022-4804(06)00425-2

doi: 10.1016/j.jss.2006.07.050

Journal of Surgical Research
Volume 140, Issue 1 , Pages 12-19 , 1 June 2007